These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8212757)

  • 1. [Nizatidine in therapy and prevention of non-steroidal anti-rheumatic drug-induced ulcers in rheumatic patients].
    Simon B; Leucht U; Amon I; Brandau J; Müller P
    Z Gastroenterol; 1993 Jun; 31(6):395-400. PubMed ID: 8212757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nizatidine in therapy and prevention of non-steroidal anti-inflammatory drug-induced gastroduodenal ulcer in rheumatic patients.
    Simon B; Müller P
    Scand J Gastroenterol Suppl; 1994; 206():25-8. PubMed ID: 7863248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nizatidine prevents peptic ulceration in high-risk patients taking nonsteroidal anti-inflammatory drugs.
    Levine LR; Cloud ML; Enas NH
    Arch Intern Med; 1993 Nov; 153(21):2449-54. PubMed ID: 8215749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ulcer healing with ranitidine and antacids despite continued therapy with non-steroidal anti-rheumatic drugs].
    Stock KP; Bach GL
    Z Rheumatol; 1988; 47(3):177-81. PubMed ID: 3213266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ranitidine in the therapy and prevention of NSAR-induced (non-steroidal anti-rheumatic agents) gastroduodenal lesions in patients with rheumatism].
    Simon B; Bergdolt H; Dammann H; Müller P
    Z Gastroenterol; 1991 May; 29(5):217-21. PubMed ID: 1950028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of non-steroidal anti-inflammatory drug-induced damage to gastric mucosa using ranitidine. Comparison of the effectiveness of 2 dosages].
    Müller P; Dammann HG; Marinis E; Weise D; Simon B
    Fortschr Med; 1989 Oct; 107(31):667-70. PubMed ID: 2687142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Healing of NSAID-induced gastric ulcers with a synthetic prostaglandin analog (enprostil).
    Sontag SJ; Schnell TG; Budiman-Mak E; Adelman K; Fleischmann R; Cohen S; Roth SH; Ipe D; Schwartz KE
    Am J Gastroenterol; 1994 Jul; 89(7):1014-20. PubMed ID: 8017358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Misoprostol prevents NSAID-induced gastroduodenal lesions in patients with osteoarthritis and rheumatoid arthritis.
    Saggioro A; Alvisi V; Blasi A; Dobrilla G; Fioravanti A; Marcolongo R
    Ital J Gastroenterol; 1991; 23(3):119-23. PubMed ID: 1742504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double blind, placebo controlled trial on the cytoprotective effect of misoprostol in subjects with rheumatoid arthritis, osteoarthritis and seronegative spondarthropathy on NSAIDs.
    Chandrasekaran AN; Sambandam PR; Lal HM; Ramakrishnan S; Porkodi R; Krishnamurthy V; Achutan K
    J Assoc Physicians India; 1991 Dec; 39(12):919-21. PubMed ID: 1816217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of non-steroidal antirheumatic drug-induced gastrointestinal lesions with misoprostol].
    Bach GL; Stock KP; Hüdepohl M
    Z Rheumatol; 1991; 50(3):175-80. PubMed ID: 1927064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis.
    Goldstein JL; Huang B; Amer F; Christopoulos NG
    Clin Ther; 2004 Oct; 26(10):1637-43. PubMed ID: 15598480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy of antihelicobacter therapy in NSAID-induced gastropathies].
    Karateev AE; Murav'ev IuV; Radenska-Lopovok SG; Nasonova VA
    Klin Med (Mosk); 2003; 81(8):37-41. PubMed ID: 14520944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention with sucralfate gel of NSAID-induced gastroduodenal damage in arthritic patients.
    Miglioli M; Bianchi Porro G; Vaira D; Menegatti M; Brunetti G; Petrillo M; Ardizzone S; Frizziero L; Montrone F; Grandinetti G
    Am J Gastroenterol; 1996 Nov; 91(11):2367-71. PubMed ID: 8931419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiology of antirheumatic drug-induced ulcer in comparison with peptic gastroduodenal ulcer. Five-year analysis of a hospital patient sample].
    Benz J; Wiedbrauck F; Hotz J
    Med Klin (Munich); 1993 Aug; 88(8):463-70. PubMed ID: 8413047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misoprostol and ranitidine in the prevention of NSAID-induced ulcers: a prospective, double-blind, multicenter study.
    Raskin JB; White RH; Jaszewski R; Korsten MA; Schubert TT; Fort JG
    Am J Gastroenterol; 1996 Feb; 91(2):223-7. PubMed ID: 8607484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-steroidal anti-inflammatory drug gastropathy: clinical results with misoprostol.
    Koch M
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S54-62. PubMed ID: 10379471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis.
    Goldstein JL; Correa P; Zhao WW; Burr AM; Hubbard RC; Verburg KM; Geis GS
    Am J Gastroenterol; 2001 Apr; 96(4):1019-27. PubMed ID: 11316141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development and relapse of gastroduodenal ulcer in patients taking nonsteroid anti-inflammatory drugs: effects of standard risk factors].
    Karateev AE; Nasonova VA
    Ter Arkh; 2008; 80(5):62-6. PubMed ID: 18590118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of colloid bismuth subcitrate (De-Nol) in gastropathies induced by nonsteroid anti-inflammatory drugs: an open controlled 4-week trial].
    Karateev AE; Nasonov EL; Radenska-Lopovok SG
    Ter Arkh; 2005; 77(2):46-9. PubMed ID: 15807452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.